Clinical Trials on Major Depression in New Zealand

Total 1111 results

Janssen Research & Development, LLC

Completed

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Depressive Disorder, Major

United States, Belgium, Czechia, Ukraine, Poland, Malaysia, Serbia, Bulgaria, Argentina, Lithuania, Slovakia, Russian Federation, Canada, United Kingdom, Latvia
New York State Psychiatric Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse

Major Depressive Disorder | Alcohol Use Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women

Depressive Disorder | Depression | Depressive Disorder, Major

Colombia, Mexico, United States, Peru, Chile, Argentina
Duke University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); University at Buffalo

Recruiting

Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings (MTQT)

Schizophrenia | Schizoaffective Disorder | Tobacco Use Disorder | Bipolar Disorder | Mental Illness | Persistent Depressive Disorder | Recurring Major Depressive Disorder

United States
Sanofi

Completed

An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder (COMPASS)

Depressive Disorder, Major

United States, Russian Federation, Germany, Estonia, Mexico, Korea, Republic of, Chile, South Africa
Sanofi

Completed

Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine

Major Depressive Disorders

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)

Depressive Disorder, Major

United States
Allergan

Completed

OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females

Depressive Disorder, Major

United States
Janssen Research & Development, LLC

Completed

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

Depressive Disorder, Major

United States, Taiwan, Czechia, Spain, Mexico, South Africa, Colombia, Russian Federation, Brazil, Bulgaria, Sweden
Boehringer Ingelheim

Completed

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Depressive Disorder, Major

Spain, United States, Canada, Germany, Japan, Argentina, Hungary, France, Australia, Bulgaria, Czechia, Poland, Russian Federation, Slovakia
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States, Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine, United Kingdom
Biogen

Terminated

A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia

Insomnia | Major Depressive Disorder

United States
Luye Pharma Group Ltd.

Completed

Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005

Major Depressive Disorder, Recurrent, Unspecified

United States
Biogen

Completed

A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States
The University of New South Wales

Completed

Trial of Transcranial Direct Current Stimulation (tDCS) Using Alternative Electrode Montages

Major Depression

Australia
GlaxoSmithKline

Completed

A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder

Depressive Disorder, Major

United States
Janssen Research & Development, LLC

Terminated

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Depressive Disorder, Major

United States, Korea, Republic of, Malaysia, Poland, Finland, Chile, Argentina, Slovakia, Ukraine, Denmark
Janssen Research & Development, LLC

Completed

54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide (Aspire I)

Depressive Disorder, Major

United States, Korea, Republic of, Malaysia, Taiwan, Bulgaria, Spain, Hungary, Germany, Estonia, South Africa, Slovakia
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH); University of California, Davis

Recruiting

Invasive Decoding and Stimulation of Altered Reward Computations in Depression

Major Depressive Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Mechanisms of Emotion Regulation Underlying Successful CBT in Depression

Major Depressive Disorder

United States
New York State Psychiatric Institute

Completed

Ketamine Treatment Effects on Synaptic Plasticity in Depression

Major Depressive Disorder

United States
Columbia University

Terminated

The Role of HNKs in the Antidepressant Effect of Ketamine

Major Depressive Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms

Major Depressive Disorder

United States
Janssen Research & Development, LLC

Completed

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

Depressive Disorder, Major

United States, Poland, United Kingdom, Russian Federation, Canada
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, Germany, Poland, Hungary, Slovakia
Icahn School of Medicine at Mount Sinai

Recruiting

Real-time Biofeedback With 7-Tesla MRI for Treatment of Depression (Biofeedback)

Major Depressive Disorder

United States
New York State Psychiatric Institute
University of Haifa

Completed

Contact: Developing New Clinical Management Strategies

Major Depressive Disorder

United States
New York State Psychiatric Institute

Completed

Mechanisms of Antidepressant Non-Response in Late-Life Depression

Major Depressive Disorder

United States
The University of New South Wales
Singapore General Hospital

Completed

Trial of Transcranial Direct Current Stimulation (tDCS)

Major Depression

Singapore, Australia
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Korea, Republic of, United States, Hungary, Poland, Spain, Serbia, Estonia, Bulgaria, Mexico, Russian Federation, Ukraine, Canada, Colombia, France, Germany, Israel, Italy, Latvia, South Africa
The University of New South Wales

Completed

Home-Administered Trial of Direct Current Stimulation (HAT-DCS)

Major Depression

Australia
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH)

Completed

Treatment Choices for Improving Adherence and Outcome

Major Depression

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) (Polaris)

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, Russian Federation, Hungary, Romania, Ukraine, Canada, Germany
Zealand University Hospital
University of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...

Completed

The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome (MEDACIS)

Depression | Acute Coronary Syndrome

Denmark
Kessler Foundation
National Institute of Neurological Disorders and Stroke (NINDS); Moss Rehabilitation...

Recruiting

MRI Markers of Feedback Timing During Learning in Individuals With TBI With and Without Clinical Depression

Traumatic Brain Injury | Major Depressive Disorder

United States
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder

Depressive Disorder, Major

United States
ProofPilot
Fisher Wallace

Active, not recruiting

Fisher Wallace Neurostimulation & Depression Study

Major Depressive Disorder

United States
New York State Psychiatric Institute

Completed

Developing New Clinical Management Strategies

Major Depressive Disorder

United States
GlaxoSmithKline

Completed

An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder

Depressive Disorder, Major

United States
Ruhr University of Bochum

Completed

Quetiapine in the Treatment of Psychotic Depression - a Pilot Study

Psychotic Depression

Germany
University of New Mexico
National Institute of Mental Health (NIMH); University of Texas Southwestern... and other collaborators

Completed

Electroconvulsive Therapy Amplitude Titration

Major Depressive Disorder

United States
Weill Medical College of Cornell University
University of Pittsburgh; University of Toronto; University of Massachusetts,...

Completed

Sustaining Remission of Psychotic Depression (STOP-PD)

Psychotic Depression

United States, Canada
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Depressive Disorder, Major

United States, Bulgaria, Ukraine, Russian Federation, Germany, Finland, Japan, France
Pfizer

Completed

Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, Poland, Serbia, Russian Federation, Germany, Canada, France
Takeda

Completed

Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Depressive Disorder, Major

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial) (Pyxis)

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, France, Poland, Canada, Slovakia
GlaxoSmithKline

Completed

An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder

Depressive Disorder, Major

United States
Northside Clinic, Australia
Wesley Mission

Completed

Ketamine as an Anaesthetic Agent in Electroconvulsive Therapy (ECT)

Major Depressive Episode

Australia
NYU Langone Health
National Institutes of Health (NIH)

Recruiting

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33 (TRIADE-R33)

Major Depressive Disorder

United States

Clinical Trials on Major Depression in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations